Results 11 to 20 of about 7,991,089 (298)

Development and Validation of the American Heart Association Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Equations

Circulation, 2023
BACKGROUND: Multivariable equations are recommended by primary prevention guidelines to assess absolute risk of cardiovascular disease (CVD). However, current equations have several limitations.
Sadiya S. Khan, Kunihiro Matsushita, Y. Sang, S. Ballew, M. Grams, A. Surapaneni, M. Blaha, A. Carson, Alexander R. Chang, E. Ciemins, A. Go, O. Gutiérrez, Shih-Jen Hwang, S. Jassal, C. Kovesdy, D. Lloyd-Jones, Michael G. Shlipak, L. Palaniappan, Laurence S. Sperling, Salim S. Virani, Katherine R. Tuttle, I. Neeland, Sheryl L. Chow, Janani Rangaswami, Michael J. Pencina, C. Ndumele, J. Coresh   +26 more
semanticscholar   +1 more source

Bivalent Prefusion F Vaccine in Pregnancy to Prevent RSV Illness in Infants.

New England Journal of Medicine, 2023
BACKGROUND Whether vaccination during pregnancy could reduce the burden of respiratory syncytial virus (RSV)-associated lower respiratory tract illness in newborns and infants is uncertain.
B. Kampmann, S. Madhi, I. Munjal, E. Simőes, B. Pahud, C. Llapur, J. Baker, Gonzalo Pérez Marc, D. Radley, Emma Shittu, Julia R Glanternik, Hasra Snaggs, James Baber, Philip Zachariah, S. Barnabas, Merlin Fausett, Tyler Adam, Nicole Perreras, M. V. van Houten, A. Kantele, Li-Min Huang, Louis J. Bont, Takeo Otsuki, Sergio L Vargas, Joanna Gullam, B. Tapiéro, R. Stein, F. Polack, H. Zar, N. B. Staerke, María Duron Padilla, Peter C. Richmond, K. Koury, Katherine Schneider, E. Kalinina, David Cooper, K. Jansen, A. Anderson, K. Swanson, W. Gruber, A. Gurtman   +40 more
semanticscholar   +1 more source

Physical, psychological, and cognitive outcomes after coronavirus disease 2019 hospitalization: a prospective study with 3-month follow-up of a Brazilian cohort

The Journal of the International Society of Physical and Rehabilitation Medicine, 2023
Context:. Post–coronavirus disease (COVID) is associated with multiple impairments. Aims:. To identify consequences of COVID 2019 (COVID-19) hospitalization, and risk factors for functional dependence 3 months after discharge.
Victor Figueiredo Leite, MD, Leandro Gonçalves Cezarino, PT, MSc, Valéria Conceição Jorge, PT, Maria do Carmo Correia de Lima, PT, PhD, Cleber Nunes da Rocha, MD, Silmara Scontre, SLP, Danielle Bianchini Rampim, MD, MSc   +6 more
doaj   +1 more source

Identifying Clusters of Health Behaviors in a Japanese Working Population at Risk for Non-Communicable Diseases: A Latent Class Analysis of 12,168 Individuals

SSM: Population Health, 2023
Introduction: Noncommunicable diseases (NCDs) have become a significant global problem. Health behaviors are associated with NCDs, and characterizing populations using a public health approach can help provide specific interventions according to their ...
Takahiro Miki, Kojiro Yamamoto, Masashi Kanai, Kento Takeyama, Maki Iwatake, Yuta Hagiwara   +5 more
doaj   +1 more source

Prevention of child sexual abuse in the USA: a scoping review protocol of US legislative policies

BMJ Open, 2023
Introduction Child sexual abuse (CSA) poses a significant threat to the health and well-being of children in the USA and globally. Many states have introduced or implemented policies to address and prevent CSA, but little research has linked the effects ...
Melissa T Merrick, Claire E Helpingstine, Catherine A Murphy, J Bart Klika   +3 more
doaj   +1 more source

Strategies to prevent surgical site infections in acute-care hospitals: 2022 Update

Infection control and hospital epidemiology, 2023
and purpose The intent of this document is to highlight practical recommendations in a concise format designed to assist acute-care hospitals in implementing and prioritizing their surgical-site infection (SSI) prevention efforts.
M. Calderwood, D. Anderson, D. Bratzler, E. Dellinger, Sylvia Garcia-Houchins, Lisa L. Maragakis, A. Nyquist, K. Perkins, Michael Anne Preas, L. Saiman, J. Schaffzin, Marin L. Schweizer, D. Yokoe, K. Kaye   +13 more
semanticscholar   +1 more source

Pitavastatin to Prevent Cardiovascular Disease in HIV Infection

New England Journal of Medicine, 2023
BACKGROUND The risk of cardiovascular disease is increased among persons with human immunodeficiency virus (HIV) infection, so data regarding primary prevention strategies in this population are needed. METHODS In this phase 3 trial, we randomly assigned
S. Grinspoon, K. Fitch, M. Zanni, C. Fichtenbaum, T. Umbleja, J. Aberg, E. Overton, C. Malvestutto, G. Bloomfield, J. Currier, E. Martínez, J. Roa, M. Diggs, E. Fulda, Kay Paradis, S. Wiviott, B. Foldyna, Sara E Looby, P. Desvigne-Nickens, Beverly L Alston-Smith, J. Leon-Cruz, S. McCallum, U. Hoffmann, Michael T. Lu, H. Ribaudo, P. Douglas   +25 more
semanticscholar   +1 more source

Britain’s Prevent Programme: An End in Sight? [PDF]

, 2014
This chapter critiques the UK’s Prevent programme since its inception in 2006, and argues that it has been significantly flawed and counter-productive from the start through its partial, monocultural focus on Muslims as an entire and undifferentiated ...
Thomas, Paul
core   +4 more sources

Postexposure Doxycycline to Prevent Bacterial Sexually Transmitted Infections

New England Journal of Medicine, 2023
BACKGROUND Interventions to reduce sexually transmitted infections (STIs) among men who have sex with men (MSM) are needed. METHODS We conducted an open-label, randomized study involving MSM and transgender women who were taking preexposure prophylaxis ...
A. Luetkemeyer, D. Donnell, J. Dombrowski, Stephanie E. Cohen, Cole Grabow, Clare E. Brown, C. Malinski, R. Perkins, Melody Nasser, C. López, E. Vittinghoff, S. Buchbinder, Hyman Scott, E. Charlebois, D. Havlir, O. Soge, C. Celum   +16 more
semanticscholar   +1 more source

Early Remdesivir to Prevent Progression to Severe Covid-19 in Outpatients

New England Journal of Medicine, 2021
Background Remdesivir improves clinical outcomes in patients hospitalized with moderate-to-severe coronavirus disease 2019 (Covid-19). Whether the use of remdesivir in symptomatic, nonhospitalized patients with Covid-19 who are at high risk for disease ...
R. Gottlieb, C. E. Vaca, R. Paredes, J. Mera, B. Webb, Gilberto Pérez, Godson Oguchi, P. Ryan, B. Nielsen, Michael Brown, Ausberto B Hidalgo, Y. Sachdeva, S. Mittal, O. Osiyemi, J. Skarbinski, K. Juneja, R. Hyland, A. Osinusi, Shuguang Chen, G. Camus, M. Abdelghany, Santosh Davies, Nicole Behenna-Renton, F. Duff, F. Marty, M. Katz, A. Ginde, Sam Brown, J. Schiffer, J. Hill   +29 more
semanticscholar   +1 more source